Chemokine (C-C Motif) Ligand 2 (CCL2) Peptid
Kurzübersicht für Chemokine (C-C Motif) Ligand 2 (CCL2) Peptid (ABIN936932)
Target
Spezies
Quelle
Applikation
-
-
Protein-Typ
- Synthetic
-
Sequenz
- ASYRRITSSK CPKEAVIFKT IVAKEICADP KQKWVQDSMD HLDKQTQTPK
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CCL2 antibody,
Alternative Names: CCL2 control peptide, CCL2 antibody Blocking Peptide, Anti-CCL2 Blocking Peptide, chemokine, C-C motif ligand 2 Blocking Peptide, GDCF-2 Blocking Peptide, GDCF-2 HC11 Blocking Peptide, HC11 Blocking Peptide, HSMCR30 Blocking Peptide, MCAF Blocking Peptide, MCP-1 Blocking Peptide, MCP1 Blocking Peptide, MGC9434 Blocking Peptide, SCYA2 Blocking Peptide, SMC-CF Blocking Peptide, CCL2, CCL-2, CCL 2, CCL-2 Blocking Peptide, CCL 2 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
-
Hintergrund
- CCL2 is a chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. CCL2 augments monocyte anti-tumor activity. CCL2 has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. CCL2 may be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.
-
Molekulargewicht
- 11 kDa
Target
-